+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Valsartan"

From
Heart Failure Drugs - Global Strategic Business Report - Product Thumbnail Image

Heart Failure Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 179 Pages
  • Global
From
Angiotensin Receptor Blockers (ARBs) Market Report 2025 - Product Thumbnail Image

Angiotensin Receptor Blockers (ARBs) Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Ischemic Heart Disease (IHD) Drugs Market Report 2025 - Product Thumbnail Image

Ischemic Heart Disease (IHD) Drugs Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Anti-Hypertensive Drugs Market Report 2025 - Product Thumbnail Image

Anti-Hypertensive Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Myocardial Infarction Market Report 2025 - Product Thumbnail Image

Myocardial Infarction Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
From
From
From
Loading Indicator

Valsartan is a drug used to treat high blood pressure and congestive heart failure. It belongs to a class of drugs known as angiotensin receptor blockers (ARBs). Valsartan works by blocking the action of a hormone called angiotensin II, which causes blood vessels to narrow and increases blood pressure. By blocking the action of angiotensin II, valsartan helps to relax the blood vessels and reduce blood pressure. It is also used to reduce the risk of stroke and heart attack in people with heart disease. Valsartan is a widely used drug in the cardiovascular drug market. It is used to treat a variety of conditions, including hypertension, congestive heart failure, and coronary artery disease. It is also used to reduce the risk of stroke and heart attack in people with heart disease. Valsartan is available in both generic and branded forms, and is available in a variety of dosages. Some companies in the valsartan market include Novartis, Teva Pharmaceuticals, Mylan, and Sandoz. Show Less Read more